H

H.B. Fuller Company
SWB:HB1

Watchlist Manager
H.B. Fuller Company
SWB:HB1
Watchlist
Price: 49.4 EUR 2.49% Market Closed
Market Cap: €2.7B

H.B. Fuller Company
Investor Relations

H.B. Fuller Company, a name that might not ring a bell for many, has been integral to countless products we encounter daily. Founded in 1887, this Minnesota-based company started its journey manufacturing sealing wax for food canning. Today, it stands as a global adhesive powerhouse, catering to diverse industries ranging from construction and consumer goods to automotive and electronics. The company's core operation revolves around creating specialized adhesive solutions that bind the unseen seams of industry. These adhesives serve purposes far and wide, from ensuring the structural integrity of buildings to enabling high-tech gadgetry and packaging that withstands the rigors of modern supply chains.

The way H.B. Fuller generates revenue is rooted in its strategic agility and innovation. The company's success is anchored on understanding the specific needs of its clients and developing bespoke adhesive solutions tailored to each application. By investing significantly in R&D, it remains at the cutting edge of adhesive technology, offering products that are not only effective but also environmentally sustainable. H.B. Fuller monetizes its expertise through long-term partnerships with large industrial consumers, ensuring a steady stream of income while exploring new market avenues and expanding its geographical footprint through acquisitions and alliances. This business model has not only fortified its market position but also ensured steady growth amidst evolving industry demands.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Mar 26, 2026
AI Summary
Q1 2026

Profit beat: H.B. Fuller said it delivered on its profit commitment in Q1, with adjusted EBITDA of $119 million, up 4% year over year, and margin expansion of 90 basis points to 15.4%.

Revenue fell: Organic revenue declined 6.6% as price increases were more than offset by lower volume, with volume down 7.2% in the quarter.

Guidance raised: Full-year 2026 guidance was increased on higher pricing, expected share gains and the supply shock, with adjusted EBITDA now seen at $645 million to $675 million and adjusted EPS at $4.55 to $4.90.

Price action: The company announced a minimum 10% price increase across all product lines globally effective April 1, with some technologies and regions seeing even higher increases.

Supply disruption: Management said the Middle East conflict has already caused raw material shortages, more than 40 force majeure letters from suppliers, and likely inflation and volatility for the rest of the year.

Share opportunity: Management believes the current market disruption creates an opening to gain share, especially where competitors cannot secure supply, and said it is asking for longer-term agreements from customers.

Capital priorities: The company paused near-term deal closing for M&A and will focus more cash on share repurchases while working toward its 2.5x to 3x net debt-to-EBITDA target.

Key Financials
Organic revenue
down 6.6%
Adjusted EBITDA
$119 million
Adjusted EBITDA margin
15.4%
Adjusted gross profit margin
31.3%
Adjusted EPS
$0.57
Pricing
up 0.6%
Volume
down 7.2%
Currency impact on revenue
up 3.6%
Acquisition impact on revenue
up 0.7%
Net debt to adjusted EBITDA
3.1x
Cash flow from operations
improved $49 million year over year
Quarterly revenue impact from Chinese New Year
$15 million to $20 million
Solar-related revenue
$12.5 million
Medical business in Europe organic growth
almost 20%
Earnings Call Recording
Other Earnings Calls

Management

Contacts

Address
MINNESOTA
Saint Paul
1200 Willow Lake Blvd
Contacts
+16512365900
www.hbfuller.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett